Carcinoma-associated fibroblasts (CAFs) that express a-smooth muscle actin (aSMA) contribute to cancer progression, but their precise origin and role are unclear. Using mouse models of inflammation-induced gastric cancer, we show that at least 20% of CAFs originate from bone marrow (BM) and derive from mesenchymal stem cells (MSCs). aSMA+ myofibroblasts (MFs) are niche cells normally present in BM and increase markedly during cancer progression. MSC-derived CAFs that are recruited to the dysplastic stomach express IL-6, Wnt5a and BMP4, show DNA hypomethylation, and promote tumor growth. Moreover, CAFs are generated from MSCs and are recruited to the tumor in a TGF-b-and SDF-1a-dependent manner. Therefore, carcinogenesis involves expansion and relocation of BM-niche cells to the tumor to create a niche to sustain cancer progression.
INTRODUCTION
Tumors consist of cancer cells and diverse stromal cells that constitute the tumor microenvironment and contribute to tumor progression. Stem cells or their immediate progeny can give rise to various tumor-contributing cells through a dysregulated self-renewal process (Wicha et al., 2006) , but the origin of many niche cells critical for tumor growth (Li and Neaves, 2006) has not been established. Much of the tumor stroma consists of cancer-associated fibroblasts (CAFs) that express a-smooth muscle actin (aSMA). CAFs closely resemble myofibroblasts (MFs) that are present in the gastrointestinal mucosa.
Clinical evidence supports the contribution of stroma to the development of a variety of tumors (Coussens and Werb, 2002) . In general there is a higher incidence of tumor formation in tissues with chronically inflamed stroma, particularly Helicobacter pylori gastritis, which is associated with gastric cancer (Houghton and Wang, 2005) .
Phenotypically, CAFs resemble normal gastrointestinal MFs in that they express aSMA and other MF markers such as vimentin or FSP1; biologically they are different, and it remains puzzling why CAFs would appear only in the setting of cancer, but not in the normal adult organs. Tumors that have a desmoplastic stroma, consisting of more stromal cells disrupting the tissue
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homogeneity, often have a poorer prognosis (Maeshima et al., 2002) . CAFs isolated from breast cancer tissue promote proliferation of cancer cell lines, increase angiogenesis to a greater extent, and have a distinct gene expression pattern compared to normal fibroblasts (Allinen et al., 2004) . CAFs isolated from prostate cancer direct tumor progression of initiated prostatic epithelium and can transform nontumorigenic human prostatic epithelial cell lines into tumorigenic ones (Hayward et al., 2001) . CAFs express increased levels of the chemokine SDF-1 (Orimo et al., 2005) and genes such as Gremlin-1 that are not expressed in most normal tissues (Sneddon et al., 2006) . Finally, we recently showed that CAFs were more hypomethylated than normal gastric stromal cells (Jiang et al., 2008) .
CAFs have altered biology compared to normal MFs and seem to accumulate in tumors. A number of studies have explored the origins of CAFs, which include resident fibroblasts (Orimo et al., 2005) , smooth muscle cells, endothelial cells, epithelial cells (through EMT), fibrocytes, and bone marrow (BM)-derived cells such as mesenchymal stem cells (MSCs) (Direkze et al., 2003; Karnoub et al., 2007) . Chronic inflammation associated with increased cancer risk (Forbes et al., 2004) and tumor xenografts (Ishii et al., 2003) recruit BM-derived MFs. In gastric tumors of patients that received gender-mismatched BM transplants (BMTs), many CAFs are bone marrow derived (Worthley et al., 2009 ). However, the precise BM cell type that gives rise to CAFs remains unclear.
Several studies have pointed to MSCs as a potential source of CAFs (Guo et al., 2008) . MSCs, when mixed with weakly metastatic human breast carcinoma cells, increase the metastatic abilities of cancer cells (Karnoub et al., 2007) . MSCs exposed to tumor-conditioned medium assume a CAF-like phenotype, including sustained expression of SDF-1 and the ability to promote tumor cell growth (Mishra et al., 2008) . MSCs are defined as pluripotent stem cells that contribute to normal bone, adipose, cartilage, and muscle (Pittenger et al., 1999) . MSCs originate in the BM but can be found throughout the body; they are often involved in tissue remodeling after injury or chronic inflammation. BM-derived cells (BMDCs) are often recruited to carcinogenic sites by cytokines such as IL-1b (Houghton et al., 2004; Tu et al., 2008) , and indeed, CAFs promote further cell recruitment through secretion of chemokines such as SDF-1 (Orimo et al., 2005) . MSCs are among the BMDCs that have been shown to be recruited to tumors and to promote their growth. Although some studies have suggested that MSCs can differentiate into CAFs, the differentiation of MSCs into CAFs or MFs has, to our knowledge, not been demonstrated conclusively (Stappenbeck and Miyoshi, 2009) . In this study we aimed to investigate the cellular origin and role of CAFs within the BM and analyzed their function in normal BM and in the tumor microenvironment.
RESULTS
aSMA+ MFs Increase with Gastric Dysplasia and Contribute to a Desmoplastic Tumor Microenvironment To understand the changes that occur in stromal cells during gastric cancer progression, we analyzed aSMA-RFP transgenic mice that express RFP under the direction of the aSMA promoter and collagen-a1-EGFP transgenic mice that express EGFP under the control of the collagen-a1 promoter (Magness et al., 2004) . A tissue-specific expression pattern for the 3 kb aSMA promoter fragment-driven RFP relative to endogenous aSMA expression was confirmed in gastric mucosa ( Figure 1D ; see Figure S1A available online). Both sets of mice were infected with Helicobacter felis (H. felis), resulting in chronic gastritis, atrophy, metaplasia, and dysplasia ( Figure S1B ). In uninfected mice, few aSMA-RFP+ MFs were present in gastric tissue, whereas collagen-a1/EGFP+ stromal cells were abundant ( Figures 1A and 1B) . Twelve to 18 months after infection, collagen-a1/EGFP+ fibroblasts and aSMA-RFP+ fibroblasts increased with chronic inflammation and cancer progression ( Figures 1A-1C) . Although collagen-a1-EGFP+ fibroblasts were abundant at early, they increased only slightly at late stages of neoplasia; aSMA-RFP+ fibroblasts were scarce early after infection but increased markedly at later stages, particularly during dysplasia, suggesting that aSMA-RFP+ fibroblasts contribute to the neoplastic process. They were defined as MFs by their expression of endogenous aSMA and vimentin (data not shown). Similarly, aSMA/collagen-a1 double-positive cells increased with dysplasia (Figures S1C and S1D), especially in invasive or highly dysplastic regions ( Figure S1E ). Additionally, we crossed the aSMA-RFP mice with IL-1b/aSMA-RFP mice, which express human IL-1b specifically in the stomach and develop spontaneous gastric inflammation and cancer . The expression of aSMA and RFP increased by 6 and 12 months in IL-1b/aSMA-RFP mice ( Figure 1D ).
We isolated fibroblastic cells from stomachs of aSMA-RFP mice and specifically cultured the MFs using glutamine withdrawal (McKaig et al., 1999) (Figure S1F ). Sorting after four population doublings (PDs) revealed that 33% of the cells from uninfected WT mice and 70% from mice with dysplasia expressed RFP ( Figure 1E ), suggesting that aSMA/RFP+ CAFs have a growth advantage over aSMA/RFPÀ WT MFs, correlating with in vivo results. Gastric RFP+ MFs of uninfected mice grew for up to 25 PDs. In contrast, gastric RFP+ CAFs from longterm H. felis-infected mice grew much faster and up to 80 PDs. Interestingly, we observed that RFP+ cells, when cultured with sorted RFPÀ cells, appeared to be surrounded by RFPÀ cells (Figure S1G ), suggesting the possibility that RFP+ cells might be providing a niche for RFPÀ cells. In addition, RFP+ CAFs isolated from long-term infected mice with dysplasia expressed increased amounts of TGF-b, IL-6, and TNF-a compared to WT RFP+ MFs ( Figure S1H ).
BMDCs Contribute to aSMA+ CAFs in an InflammationRelated Model of Gastric Carcinogenesis
To determine how BMDCs contribute to stromal cells in an inflammation-dependent model of cancer, IL-1b mice were irradiated and transplanted with EGFPÀ (UBC-EGFP), RFPÀ (aSMA-RFP), or double-labeled (UBC-EGFP/aSMA-RFP) BM, and animals were observed for 12-14 months. Engraftment of MSCs was initially confirmed through isolation ( Figure S2A ) and characteristic differentiation ( Figure S2B ) of GFP+ MSCs isolated from BM 4 months after transplant, consistent with previously published studies (Wang et al., 2009) , confirming that mouse BM MSCs can be transplanted (Simmons et al., 1987; Yokota et al., 2006) . In vitro culture revealed that one-third of MSCs were GFP+ and, thus, donor derived ( Figure S2A ).
Transplantation of aSMA-RFP BM revealed abundant engraftment in the BM of RFP+ cells after 18 months ( Figure S2C ). In IL-1b or H. felis-infected mice that received labeled BM, the development of dysplasia was preceded by the influx of a large number of labeled cells (Figure 2A ; Figure S2D ). Although a large proportion of the EGFP+ cells were immune cells (e.g., lymphocytes and myeloid cells), 12 months after BMT in IL-b mice, and 18 months after BMT in H. felis-infected mice, approximately 20% of aSMA+ cells in regions of gastric dysplasia were EGFP+ (Figures 2A and 2C ; Figure S2D ), whereas few if any double-positive (aSMA+/EGFP+) cells were found in uninfected WT mice. To quantify the BMDCs, we transplanted BM from UBC-GFP/aSMA-RFP mice into WT H. felis-infected, IL-1b, or 
felis).
All data are represented as mean ± SEM (see also Figure S1 ). control mice. IHC and FACS revealed that in mice with dysplasia, 20% of the GFP+ BMDCs were also RFP+ ( Figure 2B ; Figure S2E ). These findings point to a role for aSMA+/EGFP+ cells in inflammationinduced carcinogenesis.
We isolated and cultured MFs and CAFs from the stomachs of EGFP+ BMtransplanted 12-month-old WT and IL-1b mice to determine the contribution of BMDCs to the MF population (Figure S2F) . After four PDs, more than 70% of CAFs from IL-1b mice (with dysplasia) were EGFP+, indicating their BM origin. Culture of RFP+/GFP+ CAFs ( Figure 2F ) from double-transgenic donors further confirmed that aSMA+ cells were BM derived. After sorting, the vast majority of EGFPÀ cells survived only a few PDs, whereas EGFP+ CAFs proliferated and could be cultured for at least 80 PDs and expressed MF markers (aSMA, vimentin), but not epithelial markers (E-cadherin; data not shown). No cells in the MF or CAF populations were positive for CD31, CD45, CD3e, CD11b, CD45R/B220, Ly6G, Ly-6C, or TER-119 based on FACS analysis (data not shown), indicating no contamination with leukocytes. BM-derived CAFs expressed significantly higher mRNA levels of TNF-a, IL-6, SDF-1, and TGF-1b ( Figures S2G and S2H ), compared to WT MFs.
These data suggest that a significant population of CAFs in the tumor microenvironment of inflammation-induced gastric cancer is BM derived and contributes to tumor promotion.
Because resident CAFs could only be cultured for two to three passages and, thus, could not be used for extensive comparison to BM-derived CAFs, we additionally isolated total RFP(+) gastric CAFs (HF-CAF) from aSMA-RFP mice and compared them to (G) Gene expression data after FACS of GFP(À) and GFP(+) CAFs from a BM-transplanted H. felisinfected IL-1b mouse. qRT-PCR for expression of GFP, CXCL1, CCL5, SSP1, CXCR4, MMP9, IL-6, IL-1b, SDF-1a, and TNFa (copies are calculated per 10,000 copies of GAPDH; *p < 0.05 compared to all other cells). All data are represented as mean ± SEM (see also Figure S2 and Table S1 ).
GFP(+) BM-derived gastric CAFs (BMCAFs). Only 20% of HF-CAFs were BM derived. We compared their gene expression directly after FACS ( Figure S2I and Table S1 ). BM-CAFs expressed higher levels of inflammatory genes (IL-6, IL-1b, IL-33) and a number of tumor and stem cell-associated factors (CCL5, SPP1, Notch3, MMP9, CD47, CXCR4, PARP10) compared to HF-CAFs. To confirm that this gene expression signature represents the BM-derived fraction of the CAFs, we separated BM-transplanted GFP+ gastric CAFs from resident GFPÀ gastric CAFs from H. felis-infected IL-1b mice after short-term in vitro culture by FACS and analyzed their gene expression. BM-CAFs demonstrated an expression profile of selected inflammatory genes similar to what we observed using microarray ( Figure 2G ). We compared the gene expression signature of our BMderived CAFs with a previously reported inflammatory gene signature for skin CAFs (Erez et al., 2010) . Four out of the seven key inflammatory signature genes proposed by Erez et al. (2010) were also upregulated (p < 0.05) in our gene list (CXCL1, IL-1b, IL-6, SPP1) ( Figure S2I and Table S1 ). Additionally, we identified 20 out of 60 genes with a significant (p < 0.05) log fold change within the Erez gene list that were identically up or downregulated in our comparison of BM-CAFs versus HF-CAFs. These findings suggest the possibility that this inflammatory gene signature might be largely determined by the BM-derived CAFs.
Expansion of aSMA+ MFs in the BM of Mice with Gastric Dysplasia
To characterize the BM lineage that gives rise to aSMA+ CAFs, we screened BM from aSMA-RFP mice with and without H. felis infection and BM from aSMA-RFP/IL-1b mice for aSMA+ cells. FACS analyses showed rare aSMA-RFP+ cells in the BM of uninfected control mice (0.02% ± 0.007%) ( Figure 3A ; Table S2 ) but a significant stepwise increase in aSMA-RFP+ cells in the BM from aged IL-1b transgenic mice (1.2% ± 0.18%) and mice with long-term (18 months) H. felis infection (0.9% ± 0.1%), both with gastric dysplasia ( Figure 3A ), suggesting that long-term chronic inflammation and/or dysplasia is required for remodeling of the BM. In a model of accelerated gastric cancer (H. felis in combination with N-methyl-N-nitrosourea [MNU]; Tomita et al. [2010] ), we confirmed the dependence of BM aSMA cell expansion on dysplasia ( Figure 3A ). Histopathological analysis confirmed a marked increase of RFP+ and aSMA+ cells in BM after 14 months of H. felis infection ( Figure 3B ). Although RFP+/aSMA+ cells were occasionally surrounded by small groups of CD34+ hematopoietic stem cells ( Figure S3A ), we could not confirm any significant correlation in the localization of these cell types. Whereas undetectable in uninfected control mice, we observed in the peripheral blood (0.009%) of mice with dysplasia rare RFP+ cells (Table S2) , which expressed high levels of aSMA ( Figure S3B ). In addition the MSC and CAF cultures from dysplastic stomachs were morphologically very similar. Colony-forming units (CFUs) were consistently observed when we cultured gastric CAFs in MSC-specific media ( Figure S3C ). These data indicate that accumulation of differentiated aSMA+ BMDCs in the BM and blood correlates temporally with the development of gastric dysplasia.
MSCs are a possible source for MFs, so we established MSC cultures from whole BM from uninfected aSMA-RFP mice. The cultured, adherent cells were shown to be MSCs by their ability to form CFUs ( Figure 3C ) and differentiation into adipocytes and osteoblasts ( Figures 3D and 3E ). MSCs displayed longevity and grew exponentially for up to 80 days without signs of senescence or differentiation ( Figure 4B ) and with a normal karyotype (Figure S3D) . Interestingly, MSC cultures also contained cells that expressed the RFP. Although histopathological evaluation showed a moderate number of aSMA/RFP+ cells in the BM, only 0.02% of fresh eluted whole BM expressed RFP by FACS, suggesting limitations to this extraction technique for stromal cells (Table S2) . Nevertheless, 1.1% of cells after growth for several days in culture on plastic dishes and 50% or more of cells after several PDs expressed RFP (Table S2 ), indicating that myofibroblastic differentiation is highly favored under these in vitro conditions. IHC demonstrated that the RFP+ cells expressed high levels of endogenous aSMA, FSP1, and vimentin, but low levels of collagen (Figures 3F and 3G) . These data confirm that murine BM-derived MSCs can differentiate into aSMA+ cells that resemble CAFs.
In the Heterogeneous MSC Population, aSMA(-) MSCs Give Rise to aSMA+ MFs that Function as Niche Cells With continuous culture, MSCs contained a large proportion of aSMA-RFP+ cells, indicating the heterogeneous nature, similar to the BM-derived CAF population isolated from the stomach. FACS analysis of heterogeneous MSC cultures (Table S2) revealed that the majority of cells expressed RFP (71%) at six PDs but that this RFP+ population declined with more PD. When we compared the number of RFP+ cells after six PDs, we found significantly more RFP+ cells in MSCs derived from IL-1b/aSMA-RFP mice or H. felis-infected aSMA-RFP mice, consistent with the higher number of RFP+ cells in the BM ( Figure 3A ).
MFs are characterized by expression of aSMA, vimentin, and FSP1, in contrast to fibroblasts, which express collagen-a1, or stem cells, which rarely express these markers. RFP+ cells purified from the heterogeneous RFP+/À MSCs by FACS expressed all three MF markers and, thus, are distinct from RFPÀ cells that did not express aSMA ( Figures 3F and 3G ). Collagen expression was higher in the RFPÀ population, and aSMA expression was higher in the RFP+ population ( Figure 3F) ; consistent with the concept that the RFP+ cells represent more differentiated MFs and that the RFPÀ population also differentiates into, or contains, a fibroblast-like cell type.
Analysis of the BM-derived MSCs showed that the RFPÀ cells contained the true MSC. Up to 80% of the unsorted MSCs (which we will refer to herein as RFP+/À cells) and up to 80% of the once-sorted RFPÀ cells differentiated into adipocytes and osteoblasts when grown in differentiation-specific media (Figure 3D) , whereas only $20% of RFP+ cells were able to differentiate into these cell types. RFPÀ cells generated more CFUs (17 CFUs), whereas RFP+ cells formed very few (five CFUs): RFP+/À cultures were even more efficient at colony formation (42 CFUs) ( Figure 3C ). RFPÀ cells were CD44+ but did not express Sca-1, and only 2.4% expressed c-kit, but upon differentiation into a mixed RFP+/À population, the cells expressed higher levels of c-kit and Sca-1; thus, these latter markers are characteristic for the RFP+ cells ( Figure S3E ), consistent with recent publications (Wang et al., 2009 ) indicating a dynamic change in cell surface-marker expression upon culture of MSCs.
We next established a lineage relationship in the production of aSMA+ cells from MSCs and demonstrated that RFP+ cells were derived from RFPÀ cells (schematic illustration in Figure 4D ). After a first sorting and isolation of RFPÀ cells, cultures of RFPÀ cells generated new RFP+ cells and RFPÀ cells in the same proportion with increasing numbers of RFP+ cells over time ( Figure 4A ). Sorted RFP+ cells generated more RFP+ cells, but not RFPÀ cells ( Figure 4A) ; after ten PDs they became senescent ( Figure 4B ). Interestingly, after 80 days of in vitro culture, RFPÀ and RFP+/À cells became tetraploid ( Figure S3F ) but maintained a normal karyotype in contrast to previous reports (Izadpanah et al., 2008) . These data suggest that RFPÀ cells give rise to RFP+ cells, but not vice versa ( Figure 4E ; Movie S1).
RFPÀ cells showed superior self-renewal properties compared to RFP+ cells ( Figure 4B ), consistent with the RFPÀ cells being the progenitor to RFP+ cells. To generate pure RFPÀ cells, we carried out multiple (three to five) sortings of RFPÀ cells until we could not detect any RFP/aSMA+ cells in the population. When MSC cultures were maintained in an RFPÀ state, the cells became senescent after a few passages, indicating that RFP+ cells are needed for RFPÀ cell survival. Multiple-sorted RFPÀ cells could be prevented from senescence by the addition of RFP+ cells (data not shown), suggesting that the senescence phenotype was not due to cell damage from sorting but, instead, due to the absence of secreted factors by RFP+ cells. To confirm these observations we transfected RFP+/À cells with a 3 kb aSMA-thymidine kinase (TK) construct ( Figure S4 ) in order to eliminate aSMA+ cells from the population. Freshly isolated RFP+/À MSCs, transfected with aSMA-TK, and treated for 10 days with gancyclovir (50 mM GCV), showed a complete and irreversible loss of RFP+ cells, followed by loss of RFPÀ cells ( Figure 4C ). In contrast, freshly isolated and aSMA-TK transfected RFP+/À cells grown on fetal fibroblasts (FEFs) (Okawa et al., 2007) survived and generated new RFP+ cells 1-2 days after GCV treatment ( Figures 4C; Figure S4B ). These data indicate that RFPÀ stem cells can only survive in a heterogeneous population of RFPÀ and RFP+ cells and that the RFP+ cells probably function as niche cells for the RFPÀ stem cells from which they derived.
TGF-b Induces aSMA Expression in RFP-MSCs through CXCR4/SDF1a and Upregulates Gremlin-1 To investigate mechanisms by which BM-and MSC-derived MFs are induced during progression to dysplasia, we examined the effect of growth factors on RFP+ MF production. We stimulated unsorted or sorted MSC cultures with TGF-b or PDGF, which have been strongly linked to MF differentiation. In all cell populations (RFP+, RFPÀ, and RFP+/À cells), RFP/ aSMA expression was strongly stimulated by TGF-b and to a lesser extent by PDGF, with the greatest effect on the RFPÀ population ( Figure 5A ; Figure S5A ). In addition, growth factor stimulation resulted in more rapid proliferation of RFP+ cells (Figures S5A and S5B) .
Next, we examined factors expressed by RFP+ cells that might contribute to the BM niche and tumor microenvironment. IL-6 has been associated with the development of gastrointestinal cancer (Grivennikov et al., 2009 ). BM-CAFs and WT MFs expressed high levels of IL-6 compared to parental MSCs (Figure 5C , a finding confirmed by ELISA (data not shown)). RFP+ cells also expressed higher levels of BMP4 and Wnt5A (factors known to contribute to the stem cell niche) and exhibited a CAF-like gene expression pattern ( Figure 5C ). This inflammatory gene expression profile correlated with analyses of BMderived GFP+ gastric CAFs compared to the total gastric CAF population (Table S1 ). SDF-1a, which has been associated with stromal-dependent cancer progression, was highly expressed in RFPÀ cells compared to WT MF or RFP+ cells ( Figures 5B  and 5C ). Thus, it seems likely that SDF-1a is expressed by MSCs rather than CAFs and may represent a mechanism by which MSCs regulate MF proliferation or recruitment to the niche. Therefore, we examined the effect of TGF-b stimulation on SDF-1a production by MSC. Incubation with TGF-b increased SDF1a production 5-fold in RFPÀ cells ( Figure 5B ), but not in RFP+ cells or WT MFs. TGF-b-mediated induction of proliferation and differentiation in MSCs was inhibited by the CXCR4 antagonist AD3100 (data not shown) because CXCR4 was mainly expressed on RFPÀ and RFP+/À cells ( Figure 5C ). AMD3100 reduced TGF-b-induced differentiation of RFP+/À cells into RFP+ cells in a dose-dependent matter ( Figure 5D ; Figure S5C ). Thus, TGF-b can induce MF differentiation of MSCs in part through upregulation of SDF1a in MSCs. Migration of cancer cells induced by BM-derived gastric IL-1b-MFs was significantly increased compared to WT MFs, and this effect could be inhibited by blocking CXCR4 ( Figure S5D) .
The BMP antagonist Gremlin-1 was upregulated during gastric carcinogenesis ( Figure 5F ) but was expressed at low levels in RFPÀ and RFP+ cells ( Figure 5E ). Interestingly, though, Gremlin-1 was upregulated in RFP+/À cells, suggesting that Gremlin-1 is induced by an interaction between RFP+ and RFPÀ cells. Gremlin-1 was highly expressed in CAFs, but not in WT MFs ( Figures 5C and 5E ), and TGF-b upregulated Gremlin-1 expression in RFPÀ cells, but not in RFP+ cells (Figure 5E ). In RFP+/À cells, Gremlin1 could only be detected in RFPÀ cells ( Figure 5G) , and aSMA and Gremlin-1 did not overlap in CAFs in gastric dysplasia ( Figure 5H ), indicating that Gremlin-1 is likely a marker of MSCs in their niche in the BM and tumor microenvironment. IHC revealed that the majority of Gremlin-1+ cells in IL-1b-mice transplanted with EGFP-BM were GFP+ ( Figure 5I ), indicating that Gremlin-1+ cells were largely BM derived. A recent study (Mendez-Ferrer et al., 2010) reported Nestin1 as a marker for MSCs in the BM, where MSCs contribute to the BM niche for HSCs. We observed colocalization of a subpopulation of Nestin1+ and GFP+ BM-transplanted stromal cells in gastric dysplasia ( Figure 5J ), confirming that BM-derived MSCs are present in the dysplastic stomach. Sonic hedgehog (Shh), which regulates stem cells, and Dickkopf-1 (DKK1), an inhibitor of the Wnt pathway, were also expressed mainly in RFP+/À cells, reflecting an active niche environment ( Figure 5C ).
BM-Derived MFs from Gastric Dysplasia or MSCs Induce Invasive Growth of Gastric Tumor Cells in a 3D
Organotypic Model Given the evidence that CAFs originate from BM-MSCs and are recruited to the stomach at early stages of dysplasia, we investigated interactions between tumor cells and CAFs. When cocultured with the human gastric cancer cells, AGS, RFPÀ, RFP+, and RFP+/À cells all increased the expression of RFP/ aSMA ( Figure 6A ), along with the MF markers FSP1 and vimentin (data not shown). In contrast, expression of collagen was downregulated in RFPÀ and RFP+/À cells to approximately the level found in RFP+ MFs ( Figure 6A ). Thus, coculture with tumor cells induces differentiation of MSCs toward the myofibroblastic lineage. In coculture experiments, SDF-1a levels were significantly decreased in all stromal cell populations ( Figure 6B ), particularly in the RFPÀ cells, consistent with increased differentiation of MSCs into aSMA+ MFs.
To study the biologic effects of BM-and MSC-derived MFs on tumor cells, we used a 3D organotypic cell culture system: AGS cells were laid onto an extracellular matrix (ECM) gel mixture with MSC-derived cell populations (RFPÀ, RFP+, and RFP+/À cells), normal WT gastric MFs, gastric CAFs, or BM-CAFs ( Figures  6C and 6D ). When placed on WT MFs, AGS cells grew with minimal signs of invasion, as expected for a well-differentiated, weak tumorigenic cell line in organotypic culture ( Figure 6D ). In contrast, when cultured on pooled gastric CAFs, tumor cell invasion into ECM could be detected ( Figure 6D ). However, AGS cells cultured on the RFP+ cells (19 invasion sides/cm), the RFP+/À cells (eight invasion sides/cm), and the IL-1b BM-derived CAFs (seven invasion sides/cm) revealed high levels of invasion into ECM (Figures 6C and 6D ). In contrast, nearly no invasion was observed when AGS cells were cultured on RFPÀ cells.
Given recent findings that widespread hypomethylation characterizes CAFs from human gastric tumors and from a transgenic Figure S5 ). mouse model of multistage gastric carcinogenesis (Jiang et al., 2008) , we examined the role of methylation in development of RFP+ cells. We observed significantly (p < 0.05) higher levels of DNA methylation in RFP+/À than in RFP+ cells ( Figure 6E ), supporting the concept that development of RFP+ MFs is regulated in part by hypomethylation. Incubation of mixed RFP+/À MSCs with 5-aza-dC induced DNA demethylation, increased the proportion of RFP+ cells ( Figure 6F) , and increased the degree of tumor cell invasion in the organotypic model ( Figure 6D ). Interestingly, TGF-b also induced hypomethylation in RFP+/À cells ( Figure 6E ). These findings indicate that hypomethylation of RFP+/À cells from the BM can contribute to the development of a CAF phenotype, might be sufficient to further transform nontumorigenic tumor cells, and contributes to tumor invasion. Figure S6H ). Again, we observed increased tumor growth with coinjections (data not shown), compared to only tumor cells; and stromal cells were recruited to the tumors. Tumors contained multiple BM-derived GFP+ or RFP+ cells, including aSMA+ MF-shaped cells ( Figure S6H ). Interestingly, coinjection of MSC-containing CAF preparations significantly increased the number of GFP+ BMDCs and RFP+ MFs in tumors, in contrast to few GFP+ cells in tumors of mice not given coinjections ( Figures S6G and S6H) . Thus, the recruitment of BM-derived CAFs can be accelerated by the presence of MSCs in the tumor microenvironment. Taken together, BM-and MSC-derived aSMA+ MFs can be recruited to the tumor to stimulate growth, but the combination of the RFP+ myofibroblastic cells and RFPÀ MSCs, which recreate the BM niche at the tumor site, is a particularly potent stimulant of tumor growth and responsible for further recruitment of BMDCs (see model: Figure 8G ).
BM-and MSC-Derived MFs

CXCR4/SDF1 Contributes to Migration of BM-Derived
MFs to the Tumor, Whereas TGF-b Inhibition Decreases MF Differentiation In Vivo Having shown that SDF-1a signaling modulated MF differentiation in vitro, we analyzed the importance of SDF-1a signaling in vivo. We coinjected GFP-labeled IL-1b-BM-MFs with MKN45 cells in one flank, and MKN45 cells alone in the other flank, and then administered a TGF-b receptor 2 (R2) inhibitor (SB-505124) or CXCR4 inhibitor (AMD3100) for 6 weeks. Mice given the TGF-bR2 inhibitor developed smaller tumors on both flanks ( Figures 8A and 8B ), compared with untreated control mice ( Figure 8A ). IHC revealed a decrease in total GFP-labeled and aSMA+/GFP+ MFs, suggesting less differentiation of MSCs to CAFs, consistent with the in vitro results. In mice that were given the CXCR4 inhibitor, we observed a slight decrease in tumor size on the flank that received coinjection of IL-1b BM-MFs and MKN45 cells but very small tumors on the flank only injected with tumor cells (Figures 8A and 8B ). IHC revealed no GFP+ cells with few if any aSMA-expressing MFs on the contralateral side, and a reduced number of non-GFP aSMA+ cells on the coinjection side ( Figure 8A ). These findings indicate that SDF-1a signaling is likely required for the recruitment and migration of MSCs or MFs to the tumor site.
To extend these findings, we treated H. felis-infected aSMA-RFP mice (12 months) with the CXCR4 inhibitor (5 mg/kg/day AMD3100 in four consecutive Alzetª mini pumps) for 4 months and analyzed the effects on gastric carcinogenesis and aSMA/ RFP+ BMDCs. CXCR4 antagonism resulted in a marked reduction in aSMA+ cells in the BM of the treated mice, which seemed to be replaced by fat cells ( Figures 8E and 8F) ; it led to a reduction in gastric aSMA+ cells ( Figure 8C ) and inhibited the development of gastric dysplasia compared to untreated control mice ( Figure 8D ). The findings are consistent with the model in which targeted inhibition of BM aSMA+ MF production reduces cancer progression, although we cannot completely exclude a direct effect of the CXCR4 antagonist on the development of dysplasia.
DISCUSSION
Although it is widely accepted that tumorigenesis is regulated by interactions between tumor cells and CAFs, the precise origin and function of CAFs have been unclear. We show that: (1) CAFs increase during chronic inflammation and gastric cancer progression, particularly during the transition to dysplasia; (2) CAFs are derived from aSMA+ MFs present in the normal BM; and (3) aSMA+ MFs are generated from MSCs and contribute to the normal BM niche and MSC self-renewal. During chronic inflammation and carcinogenesis, these aSMA+ BM niche cells are expanded in a TGF-b-dependent matter and recruited through CXCR4/SDF1a signaling together with Gremlin-1-expressing MSCs to incipient tumors where they contribute to a tumor niche that promotes and sustains tumor progression.
In inflammation-dependent models of gastric cancer, progression to dysplasia is associated with accumulation of aSMA-expressing CAFs, compared to collagen-a1-expressing fibroblasts. aSMA-expressing CAFs could in theory originate from local fibroblasts, endothelial cells, mesenchymal cells, local epithelial cells during the EMT, or recruited BMDCs. Studies using RIPTag transgenic mice showed that BMDCs can give rise to CAFs and fibroblasts (Direkze et al., 2004) , which was confirmed in other cancer models (Guo et al., 2008) . More importantly, studies in patients with gastric cancer that received gender-mismatched BMTs have confirmed the BM origin of CAFs in gastric cancer (Worthley et al., 2009) . We demonstrate through BM reconstitution studies in mice that 20% of aSMA+ fibroblastic cells that accumulate in dysplasia are BM derived and that BM MSCs are the likely origin of these CAFs ( Figure 8G ). In contrast to previous reports (Simmons et al., 1987; Yokota et al., 2006) , we show here that it is indeed possible to transplant BM MSCs in the mouse. CAFs recruited from the BM are functionally more active as promoters of tumor growth and invasion compared to normal or resident fibroblasts, and exhibit a previously reported NF-kB-dependent inflammatory gene expression signature (Erez et al., 2010) , which accounts for higher levels of pro-inflammatory cytokines in CAFs (Karnoub et al., 2007; Orimo et al., 2005) .
In mouse models of inflammation-induced gastric dysplasia, aSMA+ CAFs were recruited to the stomach after first accumulating in the peripheral blood and in the BM. Indeed, the accumulation of aSMA+ cells in the BM appeared to correlate with the development of dysplasia, and suggests that carcinogenesis involves an early stage of BM remodeling. In the normal BM, MSCs are able to give rise to aSMA+ cells that morphologically and functionally behave identically to CAFs isolated from the dysplastic stomach, and these aSMA+ MF cells appear to be expanded in cancer.
Previous studies have suggested that MSCs can be induced to differentiate into CAFs, particularly when exposed to tumorconditioned media (Mishra et al., 2008) . However, we show that differentiation of MSCs into aSMA+ cells is a normal pattern of differentiation in vitro and in vivo, compatible with asymmetric stem cell division in a broad definition, although more specification regarding an intrinsic or extrinsic mechanism would be needed (Morrison and Kimble, 2006) . Moreover, aSMA+ myofibroblastic cells represent normal niche cells within the BM that maintain the self-renewal properties of MSCs. In culture, MSCs lose their proliferative potential and ability to self-renew when aSMA+ cells are specifically eliminated, and these capabilities are restored if aSMA+ cells are added back to the MSC. The aSMA-RFP transgene has allowed us to sort the heterogeneous, adherent population of BM mesenchymal cells, revealing that the true MSC is aSMA-but can give rise to aSMA+ MFs.
Most adult stem cells are extremely difficult to culture in vitro in the absence of supportive niche cells or defined growth factors, and the fact that MSCs generate their own aSMA+ niche cells clarifies the self-renewal abilities of BM MSC cultures. The concept that a stem cell is able to generate its own niche cell has precedence (Mathur et al., 2010; Snippert et al., 2010) . In addition the presence of the aSMA+ cells in the BM raises interesting questions regarding the possible role of these cells beyond support of the MSCs. The BM niche is thought to consist of osteoblasts (Lo Celso et al., 2009) , which only exist in the bone, but further studies are required to determine if CAF-like cells support the growth of stem cells beyond the MSCs.
The development of dysplasia and tumors in the stomachs of mice was associated temporally with an expansion of aSMA+ cells in the BM, which was reproduced by coculture of MSCs with gastric cancer cells, indicating the effect of a soluble, secreted factor. Previous studies have shown that coculture of MSCs with cancer cells could result in differentiation into CAFs (Mishra et al., 2008) and that DNA hypomethylation induced by 5-aza-dC promoted the differentiation of pooled human MSC cultures into CAFs. We had shown that CAFs become markedly hypomethylated during early stages of human gastric carcinogenesis (Jiang et al., 2008) . Here, we confirm that hypomethylation is sufficient to induce differentiation of CAFs and that the effect is specific for the RFPÀ MSCs. However, we also demonstrate that a soluble growth factor often secreted by tumors, TGF-b, may contribute to the development of CAFs from MSCs during tumorigenesis. Incubation of RFPÀ BM-derived MSCs with TGF-b induced DNA hypomethylation and accelerated their differentiation into aSMA+ CAFs. The promotion by TGF-b of myofibroblastic differentiation occurs in part through an SDF-1a-dependent pathway because inhibition of CXCR4 blocked this differentiation process. Thus, although global hypomethylation is a well-known feature of malignant tumors, we demonstrate that TGF-b can induce both fibroblastic differentiation and global DNA hypomethylation rapidly in vitro.
The aSMA+ MF niche cells express a number of factors that likely contribute to the stem cell niche and also maintain the self-renewal properties of incipient tumors ( Figure 8G ). Factors such as Wnt5a, BMP4, and IL-6 were highly expressed by RFP+ cells, as well as BM-derived CAFs isolated from gastric dysplasia. Wnt signaling has been shown in the gut to be important both for the maintenance of tissue stem cells and the generation of cancer stem cells (CSCs) (Brabletz et al., 2009) and recently was associated with maintaining or inducing stemness in CSCs (Vermeulen et al., 2010) . BMPs have also been linked to intestinal and hematopoietic stem cell maintenance, controlling the stem cell number through regulation of the niche size (Zhang and Li, 2005) . IL-6 appears to be required for the survival of intestinal epithelial cells and the development of inflammationassociated cancer of the gut, probably through activation of STAT-3 pathways in intestinal progenitors (Grivennikov et al., 2009) . However, although the RFP+ CAFs promoted in vitro proliferation of cancer cells in organotypic models, the RFP+/À cells, which contained MSCs and CAFs, appeared to be very important in promoting in vivo tumor growth, particularly when injected at a distance from the tumor site. These findings indicate that MSCs are required for the production or migration of CAFs over time. Our results suggest that SDF-1a is likely produced by the MSC-containing RFPÀ population, rather than the RFP+ CAFs; SDF-1a seems to function in an autocrine function to stimulate more niche cells, and a paracrine function to attract and maintain CAFs in close proximity to tumors. Thus, CXCR4 antagonism-in our xenograft studies and our gastric carcinogenesis studies-appeared to inhibit stromal cell recruitment to the tumors and also block the production of CAFs in the BM of mice with cancer. (G) Schematic drawing that depicts interactions between the BM niche (left) and the gastric cancer stroma (right). A significant portion of CAFs (red) originates from the BM and is derived from MSCs (green). The normal BM niche consists of self-renewing MSCs that give rise to MFs that resemble CAFs and likely RFP+ cells, indicating that these factors can only be expressed in a functioning stem cell niche. Gremlin-1 was expressed on RFPÀ cells, presumably the true MSCs, but mainly under the conditions when the MSCs were cultured together in a mixed RFP+/RFPÀ population. Interestingly, Gremlin-1, an antagonist of the BMP pathway, is not expressed by normal adult fibroblasts or MF from the skin or most solid organs; expression of Gremlin-1 has been reported to be unique to stromal cells in the setting of cancer (Sneddon et al., 2006) and was consistently upregulated in our model of gastric carcinogenesis. Because Gremlin-1 expression was observed only in cultures that contain MSCs and MFs/CAFs, it is possible that MSC expression of Gremlin-1 occurs in response to BMP signals from the aSMA+ myofibroblastic cells. Consistently, high levels of Gremlin-1 have been observed in mouse embryonic fibroblast cells that are capable of maintaining human embryonic stem cells in culture (Pera et al., 2004) .
In summary, we show that chronic inflammation and epithelial dysplasia lead to remodeling of the BM and expansion of aSMA+ MFs in a manner that promotes cancer growth and progression. The CAF-like MFs contribute to the niche for the MSCs, and it is this fully intact MSC niche that is recruited to the tumor site and that stimulates malignant progression. The recruitment of the niche to the tumor site can be blocked by CXCR4 inhibition, and the differentiation of MSCs can be abrogated by TGF-b inhibition. We propose a model in which during the earliest stages of inflammation-induced tumor development, the BM undergoes remodeling, mediated in part by TGF-b, and then the MSC-CAF stem cell niche promotes tumor progression through SDF-1a signaling ( Figure 8G ). These observations have implications for the early diagnosis and treatment of cancer.
EXPERIMENTAL PROCEDURES
Isolation and Culture of Cells BM cells were collected by flushing femurs of aSMA-RFP mice. MSCs were cultured in murine mesenchymal medium with supplements (MesenCult). Serial cultures of the different MSCs were performed in 10 cm dishes by plating 10 5 cells, refeeding the cells every other day, and subculturing every 4-5 days.
The doubling number of each passage was calculated with the formula PD = (n f /n 0 )/log2. WT (WT MFs), BM-derived (BM-MFs), and aSMA-RFP MFs (RFP-MFs) were isolated from the stomach of C57BL/6, IL-1b/aSMA-RFP, and aSMA-RFP reporter mice. Stomachs were cut into small pieces that were incubated with collagenase I at 37 C for 1 hr. Cells were filtered with a cell strainer and washed with PBS. Harvested cells were cultured in RPMI medium without Glutamine, supplemented with 10% FBS (Hyclone) and penicillin-streptomycin at 37 C in 5% CO 2 . Characteristic features of MFs (abundant myofibrils with dense bodies, indented nucleus, basal lamina-like structure, capacity to express aSMA, vimentin and laminin) were demonstrated in both primary and secondary cultures. Cultured cells were incubated with 35 mg/ml of 5-aza-2-deoxycitidine (Sigma) for hypomethylation experiments or 10 ng/ml of murine recombinant TGF-b1 (Invitrogen) or murine recombinant PDGF (Sigma) for growth factor stimulation experiments.
Xenograft Studies in SCID Mice
All mice studies and breeding were carried out under the approval of IACUC of Columbia University. Six to 8-week-old SCID mice were used for subcutaneous injection with a mixture of tumor cells and either RFP+, RFPÀ, or RFP+/À aSMA-MSCs (1 3 10 5 ), or GFP-labeled BM-derived MFs (1 3 10 5 ) isolated from the stomach. Human gastric cancer cell lines MKN45 and AGS or the mouse Lung Cancer cell line TC-1 was used. Mice were followed for 6 weeks after injection of tumor cells. TGF-b was inhibited in mice with 5 mg/kg of SB-505124 (hydrochloride hydrate; Sigma); CXCR4 was inhibited in mice with 5 mg/kg of AMD3100 (Sigma), as previously described (Azab et al., 2009 ).
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